World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
31013
World Ranking
10121
National Ranking
975

Overview

Paola Dazzan is affiliated with King's College London in the United Kingdom. Their research primarily spans the fields of Medicine and Neuroscience, with a significant focus on Psychiatry and Mental Health as well as Cognitive Neuroscience. Dazzan's work includes studies that intersect Public Health, Environmental and Occupational Health, Clinical Psychology, and Molecular Biology.

The scientist's research topics cover a broad range of subjects, including:

  • Schizophrenia research and treatment
  • Functional Brain Connectivity Studies
  • Maternal Mental Health During Pregnancy and Postpartum
  • Child and Adolescent Psychosocial and Emotional Development
  • Tryptophan and brain disorders
  • Mental Health Research Topics
  • Advanced Neuroimaging Techniques and Applications

Dazzan has contributed to several recent papers, notable examples include:

  • "Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis," 2020, The Lancet Psychiatry
  • "Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders," 2022, JAMA Psychiatry
  • "Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning," 2020, Brain
  • "Genetic variants associated with longitudinal changes in brain structure across the lifespan," 2022, Nature Neuroscience
  • "Resting state fMRI based multilayer network configuration in patients with schizophrenia," 2020, NeuroImage Clinical

Frequent co-authors collaborating with Dazzan include Carmine M. Pariante, René S. Kahn, Robin Murray, Benedicto Crespo-Facorro, and Philip McGuire.

The scientist's work has been published in several frequent venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Schizophrenia Bulletin
  • Biological Psychiatry
  • Psychoneuroendocrinology
  • Psychological Medicine

Best Publications

  • Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: Findings from the 3-center ÆSOP study

    James B Kirkbride;Paul Fearon;Craig Morgan;Paola Dazzan

  • Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.

    Marta Di Forti;Arianna Marconi;Elena Carra;Sara Fraietta

  • High-potency cannabis and the risk of psychosis

    Marta Di Forti;Craig Morgan;Paola Dazzan;Carmine Pariante

  • Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP study

    Paul Fearon;James B. Kirkbride;Craig Morgan;Paola Dazzan

  • Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period

    Ian Richard Jones;Prabha S. Chandra;Paola Dazzan;Louise M. Howard

  • Altering the course of schizophrenia: progress and perspectives

    Mark J. Millan;Annie Andrieux;George Bartzokis;Kristin Cadenhead

  • Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users.

    Marta Di Forti;Hannah M Sallis;Fabio Allegri;Antonella Trotta

  • Reliability and Comparability of Psychosis Patients’ Retrospective Reports of Childhood Abuse

    Helen L. Fisher;Thomas K. Craig;Paul Fearon;Kevin D. Morgan

  • The dietary pattern of patients with schizophrenia: A systematic review

    Salvatore Dipasquale;Carmine M. Pariante;Paola Dazzan;Eugenio Aguglia

  • Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings.

    S. Navari;Paola Dazzan

  • Regional gray matter volume abnormalities in the at risk mental state

    Stefan J. Borgwardt;Anita Riecher-Rössler;Paola Dazzan;Xavier Chitnis

  • Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume.

    Valeria Mondelli;Annamaria Cattaneo;Martino Belvederi Murri;Marta Di Forti

  • Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment

    Valeria Mondelli;Paola Dazzan;Nilay Hepgul;Marta Di Forti

  • Parental separation, loss and psychosis in different ethnic groups: a case-control study

    Craig Morgan;James Kirkbride;Julian Leff;Tom Craig

  • Stress Sensitivity, Aberrant Salience, and Threat Anticipation in Early Psychosis: An Experience Sampling Study

    Ulrich Reininghaus;Ulrich Reininghaus;Matthew J. Kempton;Lucia Valmaggia;Tom K. J. Craig

  • Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study.

    Paola Dazzan;Kevin D. Morgan;Kenneth G. Orr;Gerard Hutchinson

  • Confirmation that the AKT1 (rs2494732) Genotype Influences the Risk of Psychosis in Cannabis Users

    Marta Di Forti;Conrad Iyegbe;Hannah Sallis;Anna Kolliakou

  • Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis

    Valeria Mondelli;Valeria Mondelli;Simone Ciufolini;Simone Ciufolini;Martino Belvederi Murri;Stefania Bonaccorso

  • Neurological soft signs in first-episode psychosis: a systematic review

    Paola Dazzan;Robin M Murray

  • Pituitary Volume Predicts Future Transition to Psychosis in Individuals at Ultra-High Risk of Developing Psychosis

    Belinda Garner;Belinda Garner;Carmine M. Pariante;Stephen J. Wood;Dennis Velakoulis

Frequent Co-Authors

Robin M. Murray
Robin M. Murray King's College London
Craig Morgan
Craig Morgan King's College London
Carmine M. Pariante
Carmine M. Pariante King's College London
Valeria Mondelli
Valeria Mondelli King's College London
Kevin Morgan
Kevin Morgan University of Nottingham
Peter Jones
Peter Jones University of Cambridge
Marta Di Forti
Marta Di Forti King's College London
Anthony S. David
Anthony S. David University College London
Helen L. Fisher
Helen L. Fisher King's College London
Philip McGuire
Philip McGuire University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in Medicine but want to explore other healthcare careers or flexible study options, there are several online degree pathways worth considering. Many students look for programs that offer practical experience, high demand job growth, and adaptability to different lifestyles.

For those aiming to enter nursing but searching for easier admissions, nursing programs without TEAS testing requirements can be a convenient choice. These options remove common barriers to entry, making it easier to start a nursing career.

If you’re interested in the management side of healthcare, consider the best online healthcare administration degree programs, which prepare you for leadership roles in hospitals, clinics, and other medical facilities.

Nursing professionals with an associate degree can advance further through ADN to FNP programs, allowing for a seamless transition to becoming a Family Nurse Practitioner.

Finally, those interested in preventive medicine or wellness may benefit from an online dietitian degree, which opens doors in nutrition, counseling, or public health.

Best Scientists Citing Paola Dazzan

Trending Scientists

Recently Published Articles